Helstrup S - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor.

Stensgaard S, Thomsen A, Helstrup S, Meldgaard P, Sorensen BS. Stensgaard S, et al. Among authors: helstrup s. Cancers (Basel). 2023 Nov 29;15(23):5628. doi: 10.3390/cancers15235628. Cancers (Basel). 2023. PMID: 38067332 Free PMC article.

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer.

Stensgaard S, Thomsen A, Helstrup S, Meldgaard P, Sorensen BS. Stensgaard S, et al. Among authors: helstrup s. Transl Lung Cancer Res. 2023 May 31;12(5):971-984. doi: 10.21037/tlcr-22-818. Epub 2023 May 9. Transl Lung Cancer Res. 2023. PMID: 37323168 Free PMC article.

Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small cell lung cancer patients.

Maansson CT, Helstrup S, Ebert EBF, Meldgaard P, Sorensen BS. Maansson CT, et al. Among authors: helstrup s. Transl Lung Cancer Res. 2023 Jan 31;12(1):14-26. doi: 10.21037/tlcr-22-577. Epub 2023 Jan 16. Transl Lung Cancer Res. 2023. PMID: 36762069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters